OBJECTIVE: Children with cerebral palsy (CP) are smaller than normally growing children.. The association between the growth hormone (GH) axis and growth in children with CP during puberty is unknown. We compared growth and markers of the GH axis in pre-pubertal and pubertal children with moderate to severe CP and without CP over a three-year period. STUDY DESIGN: Twenty children with CP, ages 6-18, Gross Motor Function Classification System levels III-V, were compared to a group of sixty-three normally growing children of similar age. Anthropometry, Tanner stage, bone age, and laboratory analyses were performed every six months for three years. Laboratory values included spontaneous overnight GH release, fasting IGF-1 and IGFBP-3. Repeated measures models were used to evaluate interactions among Tanner stage and group (children with CP vs. reference children), taking into account gender, age, and nutritional status. RESULTS: Children with CP grew more slowly than those without CP at all Tanner stages (p<0.01). Patterns of IGF-1 and GH secretion in children with CP were similar to those of the reference group; however, the concentrations of IGF-1 (p<0.01) and GH (p<0.01) were lower in girls with CP, with a similar trend for boys (p=0.10 and 0.14, respectively). CONCLUSIONS: Diminished circulating IGF-1 and GH concentrations may explain the differences in growth between the two groups.
OBJECTIVE:Children with cerebral palsy (CP) are smaller than normally growing children.. The association between the growth hormone (GH) axis and growth in children with CP during puberty is unknown. We compared growth and markers of the GH axis in pre-pubertal and pubertal children with moderate to severe CP and without CP over a three-year period. STUDY DESIGN: Twenty children with CP, ages 6-18, Gross Motor Function Classification System levels III-V, were compared to a group of sixty-three normally growing children of similar age. Anthropometry, Tanner stage, bone age, and laboratory analyses were performed every six months for three years. Laboratory values included spontaneous overnight GH release, fasting IGF-1 and IGFBP-3. Repeated measures models were used to evaluate interactions among Tanner stage and group (children with CP vs. reference children), taking into account gender, age, and nutritional status. RESULTS:Children with CP grew more slowly than those without CP at all Tanner stages (p<0.01). Patterns of IGF-1 and GH secretion in children with CP were similar to those of the reference group; however, the concentrations of IGF-1 (p<0.01) and GH (p<0.01) were lower in girls with CP, with a similar trend for boys (p=0.10 and 0.14, respectively). CONCLUSIONS: Diminished circulating IGF-1 and GH concentrations may explain the differences in growth between the two groups.
Authors: Gordon Worley; Christine M Houlihan; Marcia E Herman-Giddens; Maureen E O'Donnell; Mark Conaway; Virginia A Stallings; W Cameron Chumlea; Richard C Henderson; Ellen B Fung; Peter L Rosenbaum; Lisa Samson-Fang; Gregory S Liptak; Randy E Calvert; Richard D Stevenson Journal: Pediatrics Date: 2002-11 Impact factor: 7.124
Authors: G S Liptak; M O'Donnell; M Conaway; W C Chumlea; G Wolrey; R C Henderson; E Fung; V A Stallings; L Samson-Fang; R Calvert; P Rosenbaum; R D Stevenson Journal: Dev Med Child Neurol Date: 2001-06 Impact factor: 5.449
Authors: Steven M Day; David J Strauss; Pierre J Vachon; Lewis Rosenbloom; Robert M Shavelle; Yvonne W Wu Journal: Dev Med Child Neurol Date: 2007-03 Impact factor: 5.449
Authors: Richard C Henderson; Richard I Grossberg; Jeanine Matuszewski; Nitasha Menon; Julie Johnson; Heidi H Kecskemethy; Lois Vogel; Rebecca Ravas; Megan Wyatt; Steven J Bachrach; Richard D Stevenson Journal: J Pediatr Date: 2007-06-22 Impact factor: 4.406
Authors: Daniel G Whitney; Mark D Peterson; Maureen J Devlin; Michelle S Caird; Edward A Hurvitz; Christopher M Modlesky Journal: Am J Phys Med Rehabil Date: 2018-12 Impact factor: 2.159
Authors: Patrizia Bruzzi; Maria Francesca Messina; Alessandra Bartoli; Barbara Predieri; Laura Lucaccioni; Simona Filomena Madeo; Alberto Verrotti; Filippo De Luca; Lorenzo Iughetti Journal: Int J Endocrinol Date: 2017-07-16 Impact factor: 3.257
Authors: Sandra Mergler; Stella A de Man; Annemieke M Boot; Karen G C B Bindels-de Heus; Wim A R Huijbers; Rick R van Rijn; Corine Penning; Heleen M Evenhuis Journal: Pediatr Radiol Date: 2016-03-30
Authors: Maria de Las Mercedes Ruiz Brunner; Eduardo Cuestas; Florian Heinen; Andreas Sebastian Schroeder Journal: Sci Rep Date: 2022-02-03 Impact factor: 4.379